Supreme Petrochem (SPLPETRO) - Detailed Equity Research Report

1. Executive Summary & Announcement Assessment

On August 4, 2026, Supreme Petrochem Limited (SPLPETRO) held its analyst concall discussing Q1 FY27 financial performance and capex programs. Q1 FY27 saw net profit surge 189% YoY to ₹236 Cr with EBITDA margins expanding sharply to 19.53% (EBITDA ₹331 Cr) despite a 24.5% decline in overall sales volumes (70,842 MT). This spread expansion resulted from favorable international Styrene Monomer vs downstream product deltas, offset by export restrictions caused by the West Asia shipping crisis.

Simultaneously, the board re-confirmed a ₹450 Cr capex plan (including ₹325 Cr for an 80,000 TPA Polystyrene expansion to reach 380,000 TPA total capacity by Dec 2028), funded entirely through internal accruals.

Freshness Assessment: The core earnings and capex figures were already published in detailed board outcome filings on July 27, 2026. Hence, this concall detail is categorized as already_priced_in = true.

2. Ramp-Aware Execution & Revenue Impact Math

• TTM Revenue: ₹5,407 Cr | TTM PAT: ₹331 Cr
• Capex Plan: ₹450 Cr (~8.3% of TTM Revenue)
• Execution Timeline: 2.5 to 3 years (targeted commissioning by late 2028 / early 2029).
• Capacity Additions: Polystyrene capacity expands by 26.7% from 300k TPA to 380k TPA. ABS expanding in phases to 140k TPA.

Revenue & Earnings Impact Math:

1. Year 1 Uplift: Minimal impact from new PS capex (under construction). Growth in Year 1 (~5%) will rely on Phase 1 ABS production ramp-up.
2. Steady-State Revenue Uplift: 80,000 TPA PS + full ABS capacity at normalized realizations (~₹120-140/kg) will add approximately ₹1,100–1,200 Cr to annual top-line (~22% uplift on TTM revenue).
3. Steady-State EPS Uplift: Assuming normalized operating margins of 10-11% (standard non-crisis spreads), steady-state PAT uplift is estimated at ~25% above baseline FY26 levels (~₹410–425 Cr PAT).

3. Industry Context & Quality Gate

• Capital Intensity: Medium. Expansion requires modern polymerization facilities but is brownfield/greenfield on existing footprints.
• Industry Structure: Petrochemicals / Engineering Plastics. Domestic market demand grows structurally at ~9–10% CAGR driven by appliance, white goods, and automotive growth.
• Quality Gate: PASSED. The company maintains an ROCE of 19.0%, a D/E of 0.05, and >50% domestic market share in PS/EPS.

4. Valuation Context & Scenarios

• As-of Price: ₹719.9
• Trailing P/E: 41.1x (Peer median: 16.9x). The high P/E reflects cyclical bottom-of-cycle earnings in FY26, though Q1 FY27 annualized run-rate shows peak spread earnings.

Scenario Analysis (24–36 Months Horizon):

• Base Case (+25%): ABS capacity successfully ramps up and 80k TPA PS line progresses on schedule. Margins normalize to ~11% OPM. Target Price: ~₹900.
• Bull Case (+60%): Higher ABS value-addition boosts structural OPM to >14%, export routes reopen, and earnings normalize at higher structural levels. Target Price: ~₹1,150.
• Bear Case (-20%): Raw material (Styrene) price declines trigger inventory losses, domestic dumping resumes from Asian exporters, compressing OPM back toward 6-7%. Target Price: ~₹575.

5. Multibagger Rationale & Final Verdict

Supreme Petrochem is a high-quality market leader with clear balance sheet strength and credible expansion plans into higher-margin engineering plastics (ABS). However, because petrochemical margins are fundamentally cyclical and the trailing valuation (41.1x P/E) already prices in significant operational quality, a multibagger outcome (2x-3x) requires sustained high spreads across cycles rather than single-quarter spikes. Final verdict is POSSIBLE with a multibagger score of 55.

Executive Summary & Verdict Rationale

Supreme Petrochem (SPLPETRO) delivered an exceptional Q1 FY27 result alongside a key strategic capex announcement. Q1 FY27 net profit jumped 189.5% YoY to ₹237.57 Cr on a revenue growth of 22.3% YoY to ₹1,714.51 Cr. Concurrently, the board approved a ₹325 Cr investment to add 80,000 TPA of Polystyrene (PS) capacity at its Amdoshi complex, expanding total PS capacity by 26.7% to 380,000 TPA by March 2029.

While the Q1 earnings surge reflects cyclical expansion in Styrene-PS spreads and initial contributions from the newly commissioned ABS plant, the capex announcement adds structural growth visibility. With 50%+ domestic market share, zero net-debt strain (D/E 0.05), and strong return ratios (ROCE 19%), SPLPETRO is a high-quality franchise. However, because petrochemical margins remain tied to global commodity cycles and the capex will gestate over ~2.7 years, the stock is rated POSSIBLE for multibagger potential (Score: 68).

1. Ramp-Aware Execution & Financial Impact Math

• Capex Size: ₹325 Cr (6.0% of TTM revenue of ₹5,407 Cr).
• Capacity Expansion: +80,000 TPA PS on a base of 300,000 TPA (+26.7% increase).
• Timeline: Target completion March 2029 (~2.67 years execution period).
• Year-1 Revenue Uplift from Capex: 0.0%. The plant is under construction and will yield no revenue until FY29.
• Steady-State Impact (Post-FY29):
• Assuming 80% utilization on 80,000 TPA (~64,000 TPA added volume) at standard PS realizations (~₹110,000-120,000/ton), the incremental annual top-line potential is ~₹700-780 Cr.
• Relative to TTM Revenue (₹5,407 Cr), this translates to a steady-state revenue uplift of ~13.0%–14.5%.
• At normalized operating margins of 10-11%, this adds ~₹75-85 Cr EBITDA and ~₹55-60 Cr PAT (~₹2.9-3.2 EPS uplift, representing ~18% EPS uplift over TTM base).

2. Industry Context & Capital Intensity

• Capital Intensity: HIGH. Petrochemical plant expansions require substantial upfront capital for process technology, piping, safety, and utilities.
• Execution Difficulty: MODERATE. SPLPETRO is expanding at an existing site (Amdoshi complex), reducing brownfield execution risk, though environmental and import approvals are required.
• Industry Growth Rate: Structural domestic demand for engineering plastics and polymers in automotive, white goods, and packaging is growing at 8-10% CAGR.

3. Fundamental Quality & Financial Health

• Earnings Trajectory: Q1 FY27 EPS surged sharply following Q4 FY26 strength, indicating clear quarterly acceleration driven by margin recovery.
• Balance Sheet Strength: Debt is negligible at ₹126 Cr vs Net Worth of ₹2,371 Cr (D/E 0.05). The ₹325 Cr capex will be funded 100% via internal accruals.
• Return Metrics: ROCE stands at 19.0%, comfortably satisfying quality thresholds.
• Promoter & Governance: Stable promoter holding at 64.24% with no pledge or governance concerns.

4. Scenario Analysis & Calibrated Valuation

• Base Case (35% Upside over 24-36m): Normalized earnings settle around ₹550-600 Cr annual PAT as ABS ramps up to 140k TPA and new PS capacity approaches commissioning. Trailing P/E compresses from 43.2x towards a mid-cycle multiple of ~25-28x on higher forward earnings.
• Bull Case (65% Upside over 24-36m): Sustained favorable global Styrene-PS spreads, accelerated market share gains in ABS, and timely execution of the ₹325 Cr expansion lead to FY28 PAT exceeding ₹750 Cr.
• Bear Case (-20% Downside): Sharp collapse in global petrochemical spreads, input price surges, or aggressive dumping from overseas competitors compresses OPM below 6%, dragging annual PAT back to ~₹250-300 Cr.

5. Final Conclusion

Supreme Petrochem offers a robust mix of cyclical upside and structural growth via product expansion (ABS & PS). Its pristine balance sheet and market dominance make it a resilient performer. Given the long gestation of the new capex and global spread sensitivity, it qualifies as a POSSIBLE high-return candidate.